Brand Name | Status | Last Update |
---|---|---|
mexiletine hcl | 2008-04-29 | |
mexiletine hydrochloride | ANDA | 2025-02-05 |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Infections | D007239 | EFO_0000544 | — | — | 1 | — | — | — | 1 |
Hiv infections | D015658 | EFO_0000764 | B20 | — | 1 | — | — | — | 1 |
Peripheral nervous system diseases | D010523 | — | G64 | — | 1 | — | — | — | 1 |
Acquired immunodeficiency syndrome | D000163 | EFO_0000765 | B20 | — | 1 | — | — | — | 1 |
Communicable diseases | D003141 | — | — | — | 1 | — | — | — | 1 |
Nervous system diseases | D009422 | — | G00-G99 | — | 1 | — | — | — | 1 |
Drug common name | Mexiletine hydrochloride |
INN | mexiletine |
Description | Mexiletine is an aromatic ether which is 2,6-dimethylphenyl ether of 2-aminopropan-1-ol. It has a role as an anti-arrhythmia drug. It is an aromatic ether and a primary amino compound. |
Classification | Small molecule |
Drug class | — |
Image (chem structure or protein) | ![]() |
Structure (InChI/SMILES or Protein Sequence) | Cc1cccc(C)c1OCC(C)N.Cl |
PDB | — |
CAS-ID | 5370-01-4 |
RxCUI | — |
ChEMBL ID | CHEMBL1200606 |
ChEBI ID | 6917 |
PubChem CID | 4178 |
DrugBank | DB00379 |
UNII ID | 1U511HHV4Z (ChemIDplus, GSRS) |